Electrolyte imbalances: a complete nursing reference

Electrolyte imbalances rank among the most common – and most dangerous – clinical findings nurses encounter. A potassium level that drifts two points too high can trigger a fatal cardiac arrhythmia. A sodium that drops too fast during correction can cause permanent brain damage. Recognizing these imbalances, understanding why they happen, and knowing which interventions to prioritize are foundational nursing competencies tested heavily on the NCLEX and used daily in clinical practice.

This reference covers all five major electrolytes: sodium, potassium, calcium, magnesium, and phosphate. For each one, you will find normal ranges, causes of both the high and low states, clinical presentation, EKG changes where relevant, and priority nursing interventions. For the mnemonic-based approach to electrolyte recall, see the companion electrolyte imbalances mnemonics guide.

Quick reference table: all electrolyte imbalances at a glance

This master table summarizes each imbalance in a single view. Bookmark it, print it, or screenshot it for clinical rotations.

Sodium (Na⁺): 135–145 mEq/L

Sodium is the primary extracellular cation and the main driver of serum osmolality. Sodium imbalances are fundamentally water-balance problems – when sodium is low, there is typically too much water relative to sodium; when sodium is high, there is too little water.

Hyponatremia: causes, symptoms, and nursing interventions

Hyponatremia (serum Na⁺ below 135 mEq/L) is the most common electrolyte abnormality encountered in hospitalized patients. It can develop through sodium loss, water excess, or a combination of both.

Common causes:

• SIADH (syndrome of inappropriate antidiuretic hormone) – the body retains excess free water, diluting serum sodium
• Heart failure and cirrhosis – reduced effective circulating volume triggers water retention
• Thiazide diuretics – increase sodium excretion in the distal tubule
• Excessive hypotonic IV fluids or water intake – dilutional hyponatremia
• Vomiting, diarrhea, burns – direct sodium loss

Signs and symptoms:

Early symptoms include headache, nausea, and malaise. As sodium drops further, confusion, lethargy, and muscle cramps develop. Severe hyponatremia (below 120 mEq/L) can cause seizures, brain herniation, respiratory arrest, and death. The severity of symptoms correlates more with how rapidly the sodium fell than with the absolute value.

Nursing interventions:

• Fluid restriction for dilutional hyponatremia (SIADH, heart failure)
• Hypertonic saline (3% NaCl) for severe symptomatic hyponatremia – administered via infusion pump on a monitored unit
• Seizure precautions and neurological checks every 1–2 hours during acute episodes
• Correction rate limit. Correcting sodium too rapidly risks osmotic demyelination syndrome (ODS, formerly called central pontine myelinolysis), which causes irreversible neurological damage. The 2013 US expert panel caps the rise at 10–12 mEq/L in 24 hours for most patients, tightening to no more than 8 mEq/L in those at high ODS risk – serum sodium of 105 mEq/L or lower, alcohol use disorder, malnutrition, advanced liver disease, or hypokalemia. The 2014 European guideline limits the rise to 10 mEq/L in the first 24 hours and 8 mEq/L in each 24 hours after that. ODS has been documented in patients corrected within these limits, so the high-risk group warrants a slower goal than the maximum. This is one of the most critical electrolyte safety rules on the NCLEX.
• Monitor strict intake and output; daily weights

Hypernatremia: causes, symptoms, and nursing interventions

Hypernatremia (serum Na⁺ above 145 mEq/L) indicates a free water deficit relative to sodium. It occurs most often in patients who cannot access water independently – the elderly, infants, intubated patients, and those with altered mental status.

Common causes:

• Dehydration – inadequate fluid intake, fever, excessive sweating
• Diabetes insipidus – insufficient ADH causes massive free water loss through dilute urine
• Excessive sodium intake – hypertonic saline, sodium bicarbonate infusions, tube feeding without adequate free water flushes
• Osmotic diuresis – hyperglycemia

Signs and symptoms:

Intense thirst (the earliest indicator), dry and sticky mucous membranes, agitation, restlessness, confusion, and in severe cases, seizures and coma. Skin turgor is decreased; urine is concentrated.

Nursing interventions:

• Free water replacement using D5W or 0.45% normal saline
• Gradual correction – overly rapid reduction in sodium can cause cerebral edema as water rushes into brain cells
• Monitor neurological status closely during correction
• Treat the underlying cause (desmopressin for diabetes insipidus, adjust tube feeding protocols)
• Accurate intake and output; daily weights

Potassium (K⁺): 3.5–5.0 mEq/L

Potassium is the primary intracellular cation and the electrolyte most directly tied to life-threatening cardiac events. Small changes in serum potassium can produce significant cardiac conduction changes visible on EKG. For this reason, potassium imbalances demand the most urgent nursing response of any electrolyte disorder. For a broader view of where potassium fits within a full lab panel, see the nursing lab values cheat sheet.

Hypokalemia: causes, symptoms, and nursing interventions

Hypokalemia (serum K⁺ below 3.5 mEq/L) is extremely common in hospitalized patients, particularly those on diuretics, those with GI losses, and those in metabolic alkalosis.

Common causes:

• Loop and thiazide diuretics – the single most common cause in clinical practice
• Vomiting and NG suctioning – GI fluid is potassium-rich
• Diarrhea – large potassium losses through stool
• Metabolic alkalosis – hydrogen ions shift out of cells and potassium shifts in, lowering serum levels
• Insulin administration – drives potassium into cells (relevant in DKA management)

Signs and symptoms:

Skeletal muscle weakness (legs first, then arms), muscle cramps, constipation and decreased bowel sounds (smooth muscle affected), fatigue, and cardiac arrhythmias. Severe hypokalemia produces respiratory muscle weakness.

EKG changes (progressive with worsening deficit):

1. Flattened T waves
2. ST segment depression
3. Prominent U waves (a small wave after the T wave – the hallmark EKG finding of hypokalemia)
4. Prolonged PR interval

Nursing interventions:

• Oral potassium replacement (KCl tablets or liquid) for mild to moderate deficits – give with food to reduce GI upset
• IV potassium replacement for severe deficits or patients who cannot take oral – never administer IV push (can cause fatal cardiac arrest). The US potassium chloride concentrate label sets the usual limit, when serum K⁺ is above 2.5 mEq/L, at 10 mEq/h, at a concentration of up to 40 mEq/L, and 200 mEq in 24 hours. For urgent cases (K⁺ below 2.0 mEq/L with EKG changes or muscle paralysis) the label allows up to 40 mEq/h, given very cautiously with continuous EKG monitoring. Premixed bags at the highest concentrations (300 and 400 mEq/L) go through a central line only, and many hospitals require central access and telemetry for any rate above 10 mEq/h. Always via infusion pump, never by gravity.
• Cardiac monitoring – continuous telemetry for K⁺ below 3.0 mEq/L
• Hold digoxin – hypokalemia potentiates digoxin toxicity, increasing the risk of fatal arrhythmias
• Assess for concurrent hypomagnesemia (see magnesium section) – potassium repletion often fails while magnesium is also low
• Monitor renal function before aggressive replacement

For a deeper look at EKG waveform interpretation and how to identify these changes at the bedside, see the EKG interpretation guide.

Hyperkalemia: causes, symptoms, and nursing interventions

Hyperkalemia (serum K⁺ above 5.0 mEq/L in most US references) becomes dangerous as levels climb because of the risk of lethal cardiac arrhythmias. UKKA grades it as mild at 5.5–5.9, moderate at 6.0–6.4, and severe at 6.5 mmol/L or higher (mmol/L and mEq/L are equal for potassium), and any level with EKG changes is treated as an emergency. Before acting on a high value, rule out hemolysis (the most common cause of falsely elevated potassium in lab draws – a tourniquet left on too long or a difficult draw can lyse red blood cells and release intracellular potassium).

Common causes:

• Renal failure – the kidneys excrete 80–90% of daily potassium; when GFR drops, potassium accumulates
• ACE inhibitors and ARBs – reduce aldosterone-mediated potassium excretion
• Potassium-sparing diuretics (spironolactone, triamterene)
• Metabolic acidosis – hydrogen ions shift into cells and potassium shifts out
• Tissue destruction – rhabdomyolysis, burns, tumor lysis syndrome, crush injuries
• Excessive supplementation – especially in patients with impaired renal function

Signs and symptoms:

Muscle weakness (ascending pattern similar to hypokalemia – this is a common NCLEX trap), paresthesias, decreased deep tendon reflexes, and abdominal cramping with diarrhea. The greatest danger is cardiac: hyperkalemia progressively disrupts cardiac conduction.

EKG changes (progressive with rising K⁺):

1. Peaked, narrow T waves – usually described as the earliest sign (often quoted at K⁺ 5.5–6.5 mEq/L)
2. Prolonged PR interval, flattened P waves
3. Widened QRS complex (often quoted at K⁺ 6.5–8.0 mEq/L)
4. Sine wave pattern – QRS merges with T wave (often quoted above 8.0 mEq/L)
5. Ventricular fibrillation or asystole

The potassium ranges are rough teaching approximations. The EKG correlates poorly with the level: the studies UKKA reviews found peaked T waves in only about 30–36% of patients with hyperkalemia, and a patient can go from peaked T waves to ventricular fibrillation quickly. A normal EKG does not rule out dangerous hyperkalemia.

Nursing interventions (in order of urgency):

1. IV calcium gluconate – stabilizes the cardiac cell membrane within minutes. It does not lower potassium; it buys time while the other treatments work. The trigger is hyperkalemic EKG changes: the UK Kidney Association (UKKA) guideline, updated July 2026, gives 30 mL of 10% calcium gluconate over 10 minutes and does not recommend calcium when the EKG is normal. US orders are often 1–3 g, and the US label caps a bolus at 200 mg per minute, so each 1 g (10 mL) takes at least 5 minutes. Recheck the EKG after the dose.
2. Regular insulin (10 units) + glucose (25 g, for example 50 mL of 50% dextrose) – insulin drives potassium into cells. Per UKKA, potassium starts to fall within 15 minutes, reaches its lowest point (a fall of about 0.65–1.0 mmol/L) at 30–60 minutes, and stays down for up to about 2 hours before rebounding, so recheck potassium. Hypoglycemia is the main hazard and can occur up to 6 hours later. UKKA’s two-stage approach adds a 10% glucose infusion at 50 mL/h for 5 hours when the pre-treatment glucose is below 7.0 mmol/L (about 126 mg/dL), and checks glucose at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours.
3. Nebulized albuterol (salbutamol) 10–20 mg – beta-2 stimulation shifts potassium into cells, with onset within about 30 minutes. It is an adjunct to insulin-glucose and should not be used alone: up to 40% of patients with end-stage kidney disease do not respond, and non-selective beta-blockers can blunt the effect.
4. Potassium binders – sodium zirconium cyclosilicate (Lokelma, onset about 1 hour) and patiromer (Veltassa, onset about 7 hours) remove potassium from the body through the gut. Both US labels state they should not be used as emergency treatment for life-threatening hyperkalemia because of delayed onset. UKKA recommends sodium zirconium cyclosilicate in severe hyperkalemia as step 3 (“remove potassium from the body”), after calcium (when the EKG shows changes) and insulin-glucose, never in their place. Each 5 g of Lokelma contains about 400 mg of sodium, so watch for edema in heart failure.
5. Hemodialysis – definitive treatment for severe, refractory hyperkalemia, especially in kidney failure
6. Continuous cardiac monitoring until potassium normalizes

Two agents students are still routinely taught, that current guidance has moved away from:

• Sodium bicarbonate. UKKA suggests against routine IV sodium bicarbonate for acute hyperkalemia. In the studies it reviews, bicarbonate alone did not lower potassium acutely, and it adds a sodium and fluid load. Older teaching listed it as a standard third-line shifting agent.
• Sodium polystyrene sulfonate (Kayexalate). Too slow for an acute emergency: its US label warns it may be insufficient for rapid correction of severe hyperkalemia and that intestinal necrosis, which may be fatal, has been reported. UKKA no longer recommends resin binders for acute hyperkalemia, and its July 2026 update also stopped suggesting them for chronic hyperkalemia.

For full dosing detail and practice questions, see the hyperkalemia nursing guide.

Expect legacy question banks to still score bicarbonate and Kayexalate as correct answers. Know both the historical sequence and the current one.

Calcium (Ca²⁺): 8.5–10.5 mg/dL

Total serum calcium is distributed across three fractions. Roughly 40–50% circulates as ionized (free) calcium – the only physiologically active form, with a normal range of about 4.6–5.2 mg/dL (1.15–1.29 mmol/L), though reference ranges vary by laboratory. About 40–45% is bound to plasma proteins, mainly albumin, and the remaining 10–15% is complexed to anions such as bicarbonate, citrate, lactate, and phosphate. Only the ionized fraction produces clinical effects, which is why albumin matters so much when interpreting a result: a low albumin drops the total calcium without touching the ionized level, making total calcium read falsely low. The albumin-corrected estimate is corrected calcium = measured calcium + 0.8 × (4.0 − serum albumin in g/dL), though a directly measured ionized calcium is more reliable when the clinical picture is unclear. Calcium has an inverse relationship with phosphate: when one rises, the other tends to fall.

Hypocalcemia: causes, symptoms, and nursing interventions

Hypocalcemia (total Ca²⁺ below 8.5 mg/dL or ionized Ca²⁺ below about 4.6 mg/dL, or your laboratory’s lower limit) produces neuromuscular irritability because low extracellular calcium lowers the threshold for nerve firing.

Common causes:

• Hypoparathyroidism – most often post-thyroidectomy (parathyroid glands are inadvertently damaged or removed)
• Vitamin D deficiency – impairs intestinal calcium absorption
• Chronic kidney disease – reduced vitamin D activation and phosphate retention
• Acute pancreatitis – calcium deposits in areas of fat necrosis
• Massive blood transfusion – citrate preservative in banked blood binds ionized calcium

Signs and symptoms:

Numbness and tingling around the mouth, fingers, and toes. Muscle cramps progressing to tetany. Laryngospasm in severe cases (airway emergency). Seizures. Two classic bedside assessment findings:

• Chvostek sign: tap the facial nerve (just anterior to the ear) and observe for ipsilateral facial muscle twitching. Interpret cautiously – it is often absent in true hypocalcemia and common in healthy people (6 of 11 young healthy subjects in one neurology series), and in a US population sample of 3,434 adults a positive sign went with normal-to-high calcium rather than low calcium. A positive Chvostek is a reason to check a calcium level, not confirmation of the diagnosis.
• Trousseau sign: inflate a blood pressure cuff 20 mmHg above systolic pressure and hold for 2–3 minutes, watching for carpal spasm (wrist flexion with finger extension). Reported sensitivity is 94% and specificity 99%, with false positives in only 1–4% of normocalcemic individuals – the better of the two tests on both counts, and the one to trust at the bedside.

EKG change: prolonged QT interval (risk of torsades de pointes).

Nursing interventions:

• IV calcium gluconate for symptomatic or severe hypocalcemia – administer slowly (over 10–20 minutes) via infusion pump. Calcium gluconate is preferred over calcium chloride for peripheral IV administration because calcium chloride causes severe tissue necrosis if it extravasates.
• Oral calcium + vitamin D for chronic management
• Seizure precautions and a quiet environment to reduce stimulation
• Monitor for concurrent hypomagnesemia (magnesium is required for PTH secretion and action – hypocalcemia is often refractory until magnesium is repleted)
• Assess for signs of tetany, especially post-thyroidectomy: keep a tracheostomy tray at the bedside

Hypercalcemia: causes, symptoms, and nursing interventions

Hypercalcemia (total Ca²⁺ above 10.5 mg/dL) is most commonly caused by hyperparathyroidism in outpatients and malignancy in hospitalized patients. The classic mnemonic for hypercalcemia symptoms is “bones, groans, stones, psychic moans” – a useful framework that captures the major organ systems affected.

Common causes:

• Primary hyperparathyroidism – excess PTH increases bone resorption and renal calcium reabsorption
• Malignancy – bone metastases, PTH-related peptide (PTHrP) secretion by tumors
• Prolonged immobility – bone resorption increases when weight-bearing ceases
• Thiazide diuretics – decrease renal calcium excretion (opposite of loop diuretics)
• Excessive calcium or vitamin D supplementation

Signs and symptoms (bones, groans, stones, psychic moans):

• Bones: bone pain, pathologic fractures
• Groans: nausea, vomiting, constipation, abdominal pain, anorexia
• Stones: renal calculi (kidney stones), polyuria, polydipsia
• Psychic moans: confusion, lethargy, depression, personality changes, coma in severe cases
• Muscle weakness and decreased deep tendon reflexes (excess calcium depresses neuromuscular function)

EKG change: shortened QT interval.

Nursing interventions:

• IV hydration with normal saline – first-line treatment to restore volume and promote renal calcium excretion. The rate is set by the provider and titrated to urine output, with close watch for fluid overload in heart or kidney failure.
• Loop diuretics (furosemide) – no longer a routine calcium-lowering therapy, because the evidence for them is weak. They are used for fluid overload once the patient is rehydrated. Thiazide diuretics should be stopped or avoided (they reduce calcium excretion).
• Bisphosphonates or denosumab – for hypercalcemia of malignancy, the 2023 Endocrine Society guideline recommends IV hydration plus an IV bisphosphonate (zoledronic acid, pamidronate) or denosumab, which inhibit osteoclast-mediated bone resorption
• Calcitonin – lowers calcium within hours but effect wanes after about 48 hours (tachyphylaxis); the Endocrine Society suggests adding it to a bisphosphonate or denosumab when calcium is above 14 mg/dL
• Fall precautions (weakness, confusion)
• Encourage mobility when possible (immobility worsens bone resorption)
• Monitor strict intake and output; monitor renal function during aggressive hydration

Magnesium (Mg²⁺): 1.5–2.5 mEq/L

Magnesium is a cofactor in over 300 enzymatic reactions and plays a critical role in neuromuscular function, cardiac conduction, and electrolyte homeostasis. Clinically, magnesium is the “forgotten electrolyte” – frequently overlooked but essential to understand because it directly affects potassium and calcium balance. This connection has significant implications for heart failure management and other cardiac conditions.

Hypomagnesemia: causes, symptoms, and nursing interventions

Hypomagnesemia (serum Mg²⁺ below 1.5 mEq/L) is common in critically ill patients, alcoholics, and patients receiving diuretics. It frequently coexists with hypokalemia and hypocalcemia – and this is the most important clinical fact about magnesium: hypokalemia and hypocalcemia are often refractory to replacement until the magnesium deficit is corrected.

Common causes:

• Chronic alcohol use – a common cause; alcohol impairs renal magnesium reabsorption and dietary intake is poor
• Loop and thiazide diuretics – increase renal magnesium wasting
• Malnutrition and malabsorption (celiac disease, inflammatory bowel disease, short bowel syndrome)
• DKA treatment – insulin shifts magnesium intracellularly (same mechanism as potassium)
• Chronic proton pump inhibitor (PPI) use – impairs intestinal magnesium absorption
• Prolonged NG suctioning or diarrhea

Signs and symptoms:

The presentation closely mirrors hypokalemia and hypocalcemia – and for good reason: low magnesium causes both. Tremors, hyperactive deep tendon reflexes, muscle cramps, nystagmus, tetany, positive Chvostek and Trousseau signs, and cardiac arrhythmias (torsades de pointes, atrial and ventricular ectopy). Seizures in severe cases.

Nursing interventions:

• IV magnesium sulfate for severe deficits – infuse slowly (1–2 g over 1 hour). Rapid infusion can cause flushing, hypotension, and cardiac depression.
• Monitor deep tendon reflexes (DTRs) before and during infusion – loss of patellar reflex is the earliest sign of magnesium toxicity and means the infusion should be stopped immediately. This is particularly critical in obstetric patients receiving magnesium for pre-eclampsia/eclampsia.
• Cardiac monitoring – continuous telemetry
• Replace potassium and calcium concurrently if deficient (they often fail to correct until magnesium is adequate)
• Oral magnesium oxide or magnesium gluconate for mild chronic deficiency (can cause diarrhea – warn patients)
• Assess and address the underlying cause (alcohol cessation support, medication review)

Hypermagnesemia: causes, symptoms, and nursing interventions

Hypermagnesemia (serum Mg²⁺ above 2.5 mEq/L) is relatively uncommon because healthy kidneys excrete excess magnesium efficiently. It occurs almost exclusively in patients with renal impairment who are receiving exogenous magnesium, or in obstetric patients receiving high-dose magnesium sulfate for eclampsia.

Common causes:

• Renal failure combined with magnesium intake (the kidney cannot clear the load)
• Excessive magnesium-containing antacids or laxatives in patients with renal impairment (Maalox, milk of magnesia)
• Magnesium sulfate overdose during eclampsia treatment
• Adrenal insufficiency

Signs and symptoms (progressive with rising levels):

Per the FDA-approved magnesium sulfate prescribing information, the effective anticonvulsant range is 2.5–7.5 mEq/L, and toxicity progresses from there:

• Diminishing deep tendon reflexes – begins above Mg²⁺ 4 mEq/L, which falls within the therapeutic window. This is the earliest detectable change and the reason nurses check the patellar reflex before every magnesium dose in obstetric patients.
• Lethargy, drowsiness, facial flushing, hypotension and bradycardia as levels climb
• Reflexes absent and respiratory paralysis a hazard – approaching Mg²⁺ 10 mEq/L. Heart block may occur at this level or lower.
• Potentially fatal – Mg²⁺ above 12 mEq/L

Note the distinction between diminished and absent reflexes. Weakening reflexes at 4–7 mEq/L are expected during therapeutic infusion and call for reassessment; an absent reflex is a stop-the-infusion finding.

Nursing interventions:

• Stop all magnesium administration immediately
• IV calcium – the antidote for magnesium toxicity; it antagonizes the effects of excess magnesium. The magnesium sulfate label lists 10–20 mL of a 5% calcium solution, and many protocols use 1 g (10 mL of 10%) calcium gluconate, given no faster than the label’s 200 mg/min cap (at least 5 minutes per gram).
• Support ventilation if respiratory depression is present (may need intubation)
• IV normal saline to promote renal excretion (if kidneys are functional)
• Dialysis for severe hypermagnesemia in patients with renal failure
• Assess patellar reflexes, respiratory rate, and urine output regularly (the three critical parameters for magnesium toxicity monitoring)

Phosphate (PO₄³⁻): 2.5–4.5 mg/dL

Phosphate is essential for ATP production, bone mineralization, oxygen delivery (2,3-DPG in red blood cells), and acid-base buffering. It has an inverse reciprocal relationship with calcium – when phosphate rises, calcium falls, and vice versa. This relationship is the key to understanding why hyperphosphatemia produces hypocalcemia symptoms and why the ADPIE nursing process framework helps structure assessment around these interconnected values.

Hypophosphatemia: causes, symptoms, and nursing interventions

Hypophosphatemia (serum PO₄³⁻ below 2.5 mg/dL) is most clinically significant in the context of refeeding syndrome – a potentially fatal condition that develops when severely malnourished patients begin receiving nutrition.

Common causes:

• Refeeding syndrome – insulin release during refeeding drives phosphate into cells, causing precipitous drops. This is the most important cause for NCLEX and the most dangerous.
• Chronic alcoholism and malnutrition – poor dietary intake
• DKA recovery – insulin treatment shifts phosphate intracellularly
• Respiratory alkalosis – intracellular shift
• Aluminum-containing antacid abuse – binds phosphate in the gut
• TPN without adequate phosphate supplementation

Signs and symptoms:

Mild hypophosphatemia is often asymptomatic. Severe depletion (below 1.0 mg/dL) causes muscle weakness that can progress to respiratory failure (the diaphragm is a muscle), rhabdomyolysis, impaired WBC function (increased infection risk), hemolytic anemia, and confusion/seizures.

Nursing interventions:

• Oral phosphate supplementation (Neutra-Phos, sodium/potassium phosphate) for mild to moderate deficits
• IV sodium or potassium phosphate for severe deficits – infuse slowly over 4–6 hours. Monitor for hypocalcemia during repletion (the inverse relationship means rising phosphate can drop calcium).
• In refeeding syndrome: start nutrition slowly – ASPEN consensus recommendations advise beginning at roughly 10–20 kcal/kg/day in high-risk patients, giving 100 mg of thiamine before any dextrose-containing solution, and checking phosphate, potassium, and magnesium every 12 hours for the first 3 days. ASPEN grades severity by the fall from baseline in any of those three electrolytes within 5 days of reintroducing calories: 10–20% mild, 20–30% moderate, above 30% or with organ dysfunction severe. Thiamine matters as much as phosphate – untreated deficiency during refeeding causes Wernicke encephalopathy.
• Increase dietary phosphate (dairy, meat, nuts, legumes)
• Discontinue phosphate-binding medications if possible

Hyperphosphatemia: causes, symptoms, and nursing interventions

Hyperphosphatemia (serum PO₄³⁻ above 4.5 mg/dL) is most commonly seen in chronic kidney disease, where reduced glomerular filtration impairs phosphate excretion. The primary danger is the reciprocal drop in calcium.

Common causes:

• Chronic kidney disease/renal failure – by far the most common cause
• Hypoparathyroidism – PTH normally promotes renal phosphate excretion
• Excessive dietary phosphate – processed foods, dark colas, dairy
• Crush injuries and tumor lysis syndrome – cell destruction releases intracellular phosphate
• Phosphate-containing enemas or laxatives (Fleet enemas) in patients with renal impairment

Signs and symptoms:

Hyperphosphatemia itself produces few direct symptoms. The clinical problems arise from the reciprocal hypocalcemia it causes: tetany, muscle cramps, Chvostek and Trousseau signs, prolonged QT interval, and seizures. Chronic hyperphosphatemia leads to metastatic calcification – calcium-phosphate crystals depositing in soft tissues, blood vessels, and joints. This vascular calcification is a major contributor to cardiovascular mortality in dialysis patients.

Nursing interventions:

• Phosphate binders (calcium carbonate, sevelamer, lanthanum) – administered with meals to bind dietary phosphate in the GI tract and prevent absorption. Timing matters: the binder must be taken with food to work.
• Dietary phosphate restriction – limit processed foods, dark colas, dairy, organ meats
• Dialysis for severe or refractory hyperphosphatemia in renal failure patients
• Monitor and treat concurrent hypocalcemia
• Avoid phosphate-containing enemas and laxatives in renal patients
• Patient education on reading food labels for phosphate additives

EKG changes by electrolyte imbalance

Cardiac monitoring is a core nursing responsibility when managing electrolyte disorders. This table summarizes the EKG changes you need to recognize – refer to the EKG interpretation guide for waveform identification and the PR interval reference for conduction assessment.

Clinical pearl: When a patient has EKG changes consistent with hypokalemia but potassium levels are not responding to replacement, check the magnesium level. Concurrent hypomagnesemia is a common reason potassium repletion fails.

Common NCLEX confusions

Several electrolyte concepts overlap in ways that create predictable test-question traps:

Peaked T waves vs. U waves. Peaked, narrow T waves are the hallmark of hyperkalemia. U waves (a small extra wave after the T wave) are the hallmark of hypokalemia. Confusing these is one of the most common NCLEX errors. Remember: the “U” in U wave looks like a valley (low, flat) – low potassium.

Chvostek sign vs. Trousseau sign. Both point toward hypocalcemia, but they test different things and differ sharply in reliability. Chvostek is a facial nerve tap (twitching = positive) and performs poorly: it is often absent in true hypocalcemia and frequently positive in healthy people with normal calcium. Trousseau is a blood pressure cuff inflated 20 mmHg above systolic for 2–3 minutes (carpal spasm = positive), with 94% sensitivity and 99% specificity. Both can also be positive in hypomagnesemia, which makes sense given that low magnesium causes hypocalcemia.

Why hypokalemia and hypomagnesemia coexist. Low magnesium causes potassium wasting through the kidneys (magnesium normally blocks potassium secretion in the collecting duct). When patients present with stubborn hypokalemia that does not respond to potassium replacement alone, concurrent hypomagnesemia is a frequent cause. Check magnesium and replace it alongside the potassium.

Calcium gluconate uses. Calcium gluconate appears as the first-line intervention in three different imbalances: hyperkalemia with EKG changes (stabilizes the cardiac membrane), hypocalcemia (direct replacement), and hypermagnesemia (antidote). NCLEX questions may test whether you know the different mechanisms. In hyperkalemia, calcium does not lower the potassium level – it protects the heart while other treatments work. In hypermagnesemia, calcium antagonizes magnesium’s neuromuscular blocking effects.

Refeeding syndrome and phosphate. When a severely malnourished patient begins eating or receiving TPN, insulin secretion drives phosphate into cells, causing a dangerous drop in serum phosphate. The NCLEX tests this connection regularly. Any question involving a malnourished patient starting nutrition should make you think: monitor phosphate.

Related references

• Nursing lab values cheat sheet – full lab panel reference with normal ranges
• Electrolyte imbalances nursing mnemonics – SALT LOSS, FRIED SALT, MURDER, CATS, and more
• EKG interpretation cheat sheet – waveform identification and rhythm analysis
• Chvostek sign – assessment technique for hypocalcemia
• Trousseau sign – assessment technique for hypocalcemia
• DKA in nursing – electrolyte management in diabetic ketoacidosis
• Heart failure nursing – fluid and electrolyte considerations in HF
• ABG interpretation – acid-base balance and electrolyte interactions
• Head-to-toe assessment – systematic assessment framework
• ADPIE nursing process – assessment, diagnosis, planning, implementation, evaluation

This reference reflects standard adult values and evidence-based nursing practice. Normal ranges may vary slightly between laboratories. Always confirm critical values against your facility’s reference ranges and follow institutional protocols for electrolyte replacement.

References

1. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. McGraw-Hill; 2001.
2. Rennke HG, Denker BM. Renal Pathophysiology: The Essentials. 4th ed. Lippincott Williams & Wilkins; 2014.
3. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493–1499. doi:10.1056/NEJM200005183422006
4. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1–S42. doi:10.1016/j.amjmed.2013.07.006
5. Kovesdy CP. Updates in hyperkalemia: outcomes and therapeutic strategies. Rev Endocr Metab Disord. 2017;18(1):41–47. doi:10.1007/s11154-016-9384-x
6. Alfonzo A, Harrison A, Baines R, Chu A, Mann S, MacRury M. Clinical practice guideline: management of hyperkalaemia in adults. UK Kidney Association; updated July 2026. https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf
7. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder. Kidney Int Suppl. 2017;7(1):1–59. doi:10.1016/j.kisu.2017.04.001
8. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care. 2008;35(2):215–237. doi:10.1016/j.pop.2008.01.007
9. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol Regul Integr Comp Physiol. 1992;263(3 Pt 2):R734–R737. doi:10.1152/ajpregu.1992.263.3.R734
10. Mushlin PS, Gropper MA. Electrolyte and acid-base disorders. In: Miller RD, ed. Miller’s Anesthesia. 8th ed. Elsevier; 2015:1767–1808.
11. Ellison DH, Berl T. Clinical practice: the syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–2072. doi:10.1056/NEJMcp066837
12. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62(16):1663–1682. doi:10.2146/ajhp040300
13. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144–153. doi:10.1053/j.ajkd.2008.03.004
14. Viera AJ, Wouk N. Potassium disorders: hypokalemia and hyperkalemia. Am Fam Physician. 2015;92(6):487–495. PMID: 26371733
15. Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012;14(2):1–17. PMID: 22413702
16. Magnesium sulfate injection, USP – prescribing information. US Food and Drug Administration / DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=6a5d362b-7aa7-40d3-898d-09407cce0713&type=display
17. Patel M, McMahon K, Hu EW. Trousseau sign. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK557832/
18. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ. 1973;4(5893):643–646. doi:10.1136/bmj.4.5893.643
19. Anastasopoulou C, Goyal A. Hypocalcemia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2026. https://www.ncbi.nlm.nih.gov/books/NBK430912/
20. da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020;35(2):178–195. doi:10.1002/ncp.10474
21. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–G47. doi:10.1530/EJE-13-1020
22. El-Hajj Fuleihan G, Clines GA, Hu MI, et al. Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(3):507–528. doi:10.1210/clinem/dgac621
23. LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149(4):259–263. doi:10.7326/0003-4819-149-4-200808190-00007
24. Hujoel IA. The association between serum calcium levels and Chvostek sign: a population-based study. Neurol Clin Pract. 2016;6(4):321–328. doi:10.1212/CPJ.0000000000000270
25. Méneret A, Guey S, Degos B. Chvostek sign, frequently found in healthy subjects, is not a useful clinical sign. Neurology. 2013;80(11):1067. doi:10.1212/WNL.0b013e31828728bc
26. Yap E, Goldwasser P. Can ionized calcium-estimating equations replace albumin-corrected calcium? A narrative review. J Lab Precis Med. 2022;7:13. doi:10.21037/jlpm-22-16
27. US prescribing information (DailyMed), accessed October 2026: calcium gluconate injection (adult bolus no faster than 200 mg/min), potassium chloride injection concentrate (rate and concentration limits), Lokelma (sodium zirconium cyclosilicate), Veltassa (patiromer), and sodium polystyrene sulfonate suspension. https://dailymed.nlm.nih.gov/